ERSTLING Quantum Innovations

Redefining Quantum Computation — No Qubits Required We don't build quantum computers; we compute reality itself. Our proprietary method, Mathematically Executed Quantum Computation (MEQC), replaces fragile qubit-based systems with a deterministic collapse of quantum-informational states. Powered by the Erstling Equation, we unify physical dynamics and informational constraints into a solvable functional — executing true quantum outcomes without hardware, noise, or decoherence. Unlike traditional quantum methods (gate-based, annealing, tensor networks), our approach: Requires no qubits or cryogenic systems Delivers deterministic, high-confidence outputs Scales instantly — up to millions of calculations per day Powers real-world breakthroughs in: Coherion™ – Deterministic Computational Engine Powers three divisions — QuantumChem (biotech IP assets), Algotronic™ (medtech assets), and AstroSight™ (aerospace intelligence). Performs in silico generation and validation of molecular interactions, PK/PD, toxicity, stability, device performance, and orbital mechanics from first principles. No training data, no probabilistic models — only the correct answer, in minutes. QuantumChem – Biotech IP Assets Division Pre-validated, patent-ready drug assets and in silico validation for CROs, biotech, and pharma. Full-spectrum analysis in hours instead of months. Specializes in novel generation, repurposed assets with modifications, and fast-tracked candidates — skipping years of trial-and-error. Algotronic™ – Medtech IP Assets Division The medtech counterpart to QuantumChem. Generates and validates devices — biocompatibility, performance, safety, manufacturability, regulatory readiness — before prototypes are built. Specializes in novel generation, repurposed designs with modifications, and fast-tracked candidates. AstroSight™ – Aerospace Intelligence Division First-principles space intelligence for aerospace, defense, and satellites — modeling orbital dynamics, asteroid co